financetom
Business
financetom
/
Business
/
NextEra Energy Poised for 'Healthy' Q3 Earnings Growth, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NextEra Energy Poised for 'Healthy' Q3 Earnings Growth, RBC Says
Oct 22, 2024 1:00 PM

03:31 PM EDT, 10/22/2024 (MT Newswires) -- NextEra Energy (NEE) is expected to report "healthy" Q3 earnings growth, while its NextEra Energy Partners ( NEP ) unit is likely to post flat EBITDA in Q3, RBC Capital Markets said in a note Tuesday.

Both companies are scheduled to release Q3 results on Wednesday.

The spotlight will be on future growth drivers for both companies during the earnings call, the investment firm said.

NextEra Energy is looking ahead to the upcoming rate case and renewable demand, while the NextEra Energy Partners ( NEP ) unit is expected to face queries about its long-term funding structure, RBC said.

RBC said it expects NextEra Energy's management to "place a significant focus on the robustness of demand for new renewable energy" at the company's NextEra Energy Resources unit, "especially from hyperscaler and utility customers," the firm said.

RBC has an outperform rating on NextEra Energy and a $93 price target while it has a sector perform rating on NextEra Energy Partners ( NEP ) with a $29 price target.

Price: 84.13, Change: +0.09, Percent Change: +0.11

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved